谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Durvalumab with or Without Tremelimumab in Patients with Persistent or Recurrent Endometrial Cancer or Endometrial Carcinosarcoma: A Randomized Open-Label Phase 2 Study

Maria M. Rubinstein,Eric Rios Doria,Jason Konner,Stuart Lichtman, Qin Zhou,Alexia Iasonos,Debra Sarasohn,Tiffany Troso-Sandoval,Claire Friedman,Roisin O'Cearbhaill,Karen Cadoo,Chrisann Kyi,Seth Cohen,Krysten Soldan,Eric Billinson,Imogen Caird,Dasom Jang,Khalil Eid,Pooja Shah,Joyce Guillen,Carol Aghajanian,Dmitriy Zamarin,Vicky Makker

GYNECOLOGIC ONCOLOGY（2023）

引用 1|浏览65
暂无评分
关键词
Durvalumab,Tremelimumab,Endometrial cancer,Endometrial carcinosarcoma,Phase 2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要